Home > News > Centre to partly fund the cost of advanced R&D by biotech firms
December 31st, 2007
Centre to partly fund the cost of advanced R&D by biotech firms
Abstract:
The SCPP idea has been approved in principle, but would be placed before the government for formalization within a month. Meanwhile, DBT has sought industry proposals until March. Unlike the Small Business Innovation Research Initiative, or Sbiri, which is meant for small-and medium enterprises, SCPP is open to companies of all sizes.
"This would enable the industry to invest in areas like RNA interference, or RNAi, (a naturally occurring process that suppresses certain gene activity in cells and has evolved into a therapeutic technique to modulate the activity of single genes), nanotechnology-based fluidics, stem cells, et al., where the industry is currently not investing," said S. Natesh, a senior adviser at DBT in New Delhi. It would also include technologies for orphan crops, such as drought-resistant wheat and rice, those that can deal with environmental calamities, drugs and vaccines for national emergencies, and in such areas where initial commercialization looks unattractive for the industry.
Source:
livemint.com
Bookmark:
| Related News Press |
News and information
Beyond wires: Bubble technology powers next-generation electronics:New laser-based bubble printing technique creates ultra-flexible liquid metal circuits November 8th, 2024
Nanoparticle bursts over the Amazon rainforest: Rainfall induces bursts of natural nanoparticles that can form clouds and further precipitation over the Amazon rainforest November 8th, 2024
Nanotechnology: Flexible biosensors with modular design November 8th, 2024
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Govt.-Legislation/Regulation/Funding/Policy
New discovery aims to improve the design of microelectronic devices September 13th, 2024
Physicists unlock the secret of elusive quantum negative entanglement entropy using simple classical hardware August 16th, 2024
Single atoms show their true color July 5th, 2024
Announcements
Nanotechnology: Flexible biosensors with modular design November 8th, 2024
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Turning up the signal November 8th, 2024
Nanofibrous metal oxide semiconductor for sensory face November 8th, 2024
Patents/IP/Tech Transfer/Licensing
Getting drugs across the blood-brain barrier using nanoparticles March 3rd, 2023
Metasurfaces control polarized light at will: New research unlocks the hidden potential of metasurfaces August 13th, 2021
Arrowhead Pharmaceuticals Announces Closing of Agreement with Takeda November 27th, 2020
 |
||
 |
||
| The latest news from around the world, FREE | ||
 |
||
|
|
||
| Premium Products | ||
 |
||
|
Only the news you want to read!
Learn More |
||
 |
||
|
Full-service, expert consulting
Learn More |
||
|
|
||